Comparing tumours based on ER status, irrespective of molecular subtype, a higher methylation frequency was observed in ER-positive and progesterone receptor (PgR)-positive tumours (P = 0.005 and P = 0.02, respectively, t-test). The gene discussed is ESR1; the disease is neoplasm.